News
Silo Pharma, Inc. (NASDAQ:SILO) on Wednesday released results for its preclinical study evaluating SP-26. SP-26 is a ketamine ...
A mind-altering medication chemically akin to ketamine will be made cheaper to improve the lives of Australians suffering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback